Roles of Non-coding RNAs in Respiratory Syncytial Virus (RSV) Infection
Analysis of host gene expression profiles following viral infections of target cells/tissues can reveal crucial insights into the host: virus interaction and enables the development of novel therapeutics and prophylactics. Regions of the host genome that do not code for protein, encode structural, and functional non-coding RNAs that are important not only in regulation of host gene expression but also may impact viral replication. This review summarizes the role of host non-coding RNAs during replication of multiple respiratory viruses with a focus on Respiratory Syncytial Virus (RSV), an important pediatric pathogen. This review highlights the current state of knowledge and understanding regarding the function(s) of ncRNAs for respiratory viral infection and host immunity in general.
- Cremer TJ et al (2009) MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS One 4:8508Google Scholar
- Consortium RN (2015) RNAcentral: an international database of ncRNA sequences. Nucleic Acids Res 43(Database issue): D123–9Google Scholar
- Grosfeld H, Hill MG, Collins PL (1995) RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J Virol 69(9):5677–5686PubMedPubMedCentralGoogle Scholar
- Moschos SA et al (2007) Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genom 8:240Google Scholar
- Mlinaric-Galinovic G et al (2009) Does the viral subtype influence the biennial cycle of respiratory syncytial virus? Virol J 6(1):1–7Google Scholar
- Thornburg NJ, Hayward SL, Crowe JE Jr (2012) Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-kB. MBio 3(6) pii: e00220-12. doi: 10.1128/mBio.00220-12